Impeto Medical in the world

HEADQUARTERS/ HEAD OFFICES

Located in Paris, France.
www.impeto-medical.com
contact

U.S. SUBSIDIARY

Located in San Diego, CA, USA
www.sudoscan.com
contact

CHINA SUBSIDIARY

Located in Beijing, China
cn.impeto-medical.com
contact

For the rest of the world, please contact us via the contact form

Products registration

Impeto Medical complies with State and Federal regulations regarding the manufacture and sale of SUDOSCAN and EZSCAN.

European Medical device directive 93/42 (class IIa) and ISO 13485:2016 delivered by SGS Belgium, notified body 1639.

Updated: december 2021

Country Products
Europe (CE mark)
For : Belgium, Denmark, France, Germany, Italy, Luxembourg,
Netherlands, Portugal, Romania, Switzerland, Spain, United Kingdom. 		SUDOSCAN
EZSCAN
USA (FDA)SUDOSCAN
AustraliaEZSCAN
Chile EZSCAN
ChinaSUDOSCAN
EZSCAN
EgyptSUDOSCAN
EZSCAN
IndiaSUDOSCAN
EZSCAN
IrakEZSCAN
IsraelSUDOSCAN
JapanSUDOSCAN
JordanSUDOSCAN
EZSCAN
KuwaitSUDOSCAN
EZSCAN
Lebanon SUDOSCAN
EZSCAN
MexicoSUDOSCAN
MoroccoSUDOSCAN
EZSCAN
PeruSUDOSCAN
QatarSUDOSCAN
EZSCAN
TaiwanSUDOSCAN
EZSCAN
Saudi ArabiaSUDOSCAN
EZSCAN
UkraineSUDOSCAN
United Arab EmiratesSUDOSCAN
EZSCAN

More information about SUDOSCAN ?

CONTACT US Feel free to contact us with your question

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Website dedicated
to health professionals

Scroll to Top